Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
about
Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancerSubjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingNew strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillanceThe effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Differences in Uptake of Risk Reduction Strategies Among Underserved PopulationsGenetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyondOophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application.Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.Risk-reducing salpingectomy: Let us be opportunistic.Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.Deleterious BRCA1/2 mutations in an urban population of Black women.Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.Cigarette smoking in women after BRCA1/2 genetic test disclosure: a 5-year follow-up study of the GENEPSO PS cohort.Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.Experiencing the cancer of a loved one influences decision-making for breast cancer prevention.Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions.A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy
P2860
Q26773707-C80BC7FB-862E-4EC1-A6AE-041F56EEDDFFQ33589900-4FF3807E-EAAD-4FBA-BC6C-40E51D806C73Q33650424-6FA4A592-8CB8-45CB-9B2E-EDB7D442DA1EQ34994574-2410400B-1212-49AF-8CC8-862762F7C1AFQ35021170-A5CC3983-A169-4F91-B93E-11E2BFD1B126Q35565667-F640B0E1-3A17-4566-B35E-25DFB25FB341Q35777905-CE878AFC-5F2C-4741-B419-2BEB4EE20432Q36240959-92FC38DB-AFDC-4ABF-8DF0-63AC959C170BQ36313479-C44C4028-43EF-47BE-82BF-AB5A371C45FDQ36541035-88E602AC-41CE-4D84-AD37-767F51838690Q36619933-70A0B925-5159-4DF7-ABCD-0C96F5B5D092Q37356474-5152960A-3F61-4C49-997E-299BAFD87F31Q38041587-B1364244-981A-4DE4-B34E-A4D19BB514D3Q38599703-AE40F558-681D-4050-B5F0-CD54C45A0499Q39196159-4E303B08-5D01-46AD-8FC3-AD7457CBB251Q39241186-EAE2B2D9-FF01-4225-B2F6-409127565261Q40303275-8211B95F-1CF6-4415-8FEB-D14E9260B6D2Q41195564-DBEA1F35-3DCB-46CF-A60A-A12DD58C5619Q42699298-306E3EE7-644A-4332-8741-2676D55C065FQ44696764-5096050F-C24C-4CC2-9D58-C8B4E3137B78Q44941961-B6F404F9-D9EA-4BF7-BAB6-27C6F377F133Q45894751-1B857977-1392-41AE-9540-062DE28D03AAQ46206556-6B5EF500-1FD9-44F6-93C8-20EA953B1002Q46971163-43B685F8-F250-4152-A922-EBA607E8D429Q48340214-7DEEE1A9-C0EB-4A33-94CB-1EA09BFCD463Q48629272-29D7B00F-9FD9-434A-8CA4-581E62F7EF8EQ50137319-6A211F06-DDEE-494D-B276-2056B2EDA332Q51017508-C61C1C04-1CE2-45E3-B7F0-281544D1A4DAQ58580413-5257640B-A412-41A4-99E2-623FA1271BDD
P2860
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@ast
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@en
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@nl
type
label
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@ast
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@en
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@nl
prefLabel
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@ast
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@en
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@nl
P2093
P2860
P1433
P1476
Uptake and timing of bilateral ...... A1 and BRCA2 mutation carriers
@en
P2093
Angela R Bradbury
Comfort N Ibe
Grazia Artioli
James J Dignam
Laura Dudlicek
Marion Verp
Melody A White
Shelly A Cummings
P2860
P2888
P304
P356
10.1097/GIM.0B013E318163487D
P407
P577
2008-03-01T00:00:00Z
P6179
1047637451